Literature DB >> 10761979

In vivo indomethacin treatment causes microglial activation in adult mice.

M M Prechel1, C Ding, R L Washington, M S Kolodziej, M R Young.   

Abstract

The current study was undertaken to study the role of prostaglandins in regulating microglial activation. Mice were treated with indomethacin (2 microg/ml) in their drinking water to selectively inhibit cyclooxygenase activity. After 4-8 days, the effect of inhibiting prostaglandin synthesis on microglial activity was evaluated. This was accomplished by analyzing microglial expression of Mac-1 (C3 complement receptor) as an indicator of activation. Mac-1 expression was assessed by immunohistochemistry of fixed brain cryosections, and by flow cytometric analysis of immunostained single cell suspensions. Both methods demonstrated that compared to age-matched, untreated controls, brains of indomethacin-treated mice had increased levels of Mac-1 expression, suggesting an increase in the state of microglial activation. These results demonstrate the importance of prostaglandins in down regulating microglial activity, and that inhibition of prostaglandin synthesis with indomethacin may act to increase the reactivity of the brain's immune system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761979     DOI: 10.1023/a:1007588903897

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  48 in total

1.  Progressive activation of adult microglial cells in vitro.

Authors:  N Slepko; G Levi
Journal:  Glia       Date:  1996-03       Impact factor: 7.452

2.  Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production.

Authors:  A O Caggiano; R P Kraig
Journal:  J Neurochem       Date:  1999-02       Impact factor: 5.372

Review 3.  Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity.

Authors:  R L Cotter; W J Burke; V S Thomas; J F Potter; J Zheng; H E Gendelman
Journal:  J Leukoc Biol       Date:  1999-04       Impact factor: 4.962

Review 4.  Functional plasticity of microglia: a review.

Authors:  W J Streit; M B Graeber; G W Kreutzberg
Journal:  Glia       Date:  1988       Impact factor: 7.452

5.  Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.

Authors:  J Bauer; S Strauss; U Schreiter-Gasser; U Ganter; P Schlegel; I Witt; B Yolk; M Berger
Journal:  FEBS Lett       Date:  1991-07-08       Impact factor: 4.124

Review 6.  Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.

Authors:  W S Griffin; J G Sheng; M C Royston; S M Gentleman; J E McKenzie; D I Graham; G W Roberts; R E Mrak
Journal:  Brain Pathol       Date:  1998-01       Impact factor: 6.508

Review 7.  Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging.

Authors:  J C de la Torre
Journal:  Gerontology       Date:  1997       Impact factor: 5.140

Review 8.  Microglia in degenerative neurological disease.

Authors:  P L McGeer; T Kawamata; D G Walker; H Akiyama; I Tooyama; E G McGeer
Journal:  Glia       Date:  1993-01       Impact factor: 7.452

9.  Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

Authors:  S L Kunkel; R C Wiggins; S W Chensue; J Larrick
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

10.  Elevated circulating tumor necrosis factor levels in Alzheimer's disease.

Authors:  H Fillit; W H Ding; L Buee; J Kalman; L Altstiel; B Lawlor; G Wolf-Klein
Journal:  Neurosci Lett       Date:  1991-08-19       Impact factor: 3.046

View more
  2 in total

1.  Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.

Authors:  Paul T Jantzen; Karen E Connor; Giovanni DiCarlo; Gary L Wenk; John L Wallace; Amyn M Rojiani; Domenico Coppola; Dave Morgan; Marcia N Gordon
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

2.  Consistent inhibition of cyclooxygenase drives macrophages towards the inflammatory phenotype.

Authors:  Yi Rang Na; Yi Na Yoon; Dain Son; Daun Jung; Gyo Jeong Gu; Seung Hyeok Seok
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.